Phase II Trial of Pembrolizumab in Recurrent or Residual High Grade Meningioma

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Phase II Trial of Pembrolizumab in Recurrent or Residual High Grade Meningioma	Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Nerve Tissue, central nervous system cancer, meningioma, neoplasm, nervous system disorder, tumor of meninges, vascular cancer	Active, not recruiting	Phase 2	2026-06-18		NCT03279692

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Massachusetts General Hospital	758
Merck Sharp & Dohme LLC	650

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Dana Farber Cancer Institute	Boston	United States	133
Massachusetts General Hospital	Boston	United States	21

Clinical trials